Who
Steven J. O'Day
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Agenus.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $118K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Jan 2022
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,333 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —95,333 at $0.00 | filing |
| 18 Jun 2025filed 30 Jun 2025 | AGEN AgenusBiotechnology | SEC FORM 4 Code A | $194K43,497 at $4.47 | filing |
| 14 Nov 2024filed 18 Nov 2024 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 11 Jun 2024filed 18 Jun 2024 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,907 at $0.00 | filing |
| 11 Jun 2024filed 18 Jun 2024 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 5 Jan 2023filed 9 Jan 2023 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 5 Jan 2023filed 9 Jan 2023 | AGEN AgenusBiotechnology | SEC FORM 4 Code A | $268K109,381 at $2.45 | filing |
| 2 Feb 2022filed 4 Feb 2022 | AGEN AgenusBiotechnology | SEC FORM 4 Code A | $255K101,682 at $2.51 | filing |
| 6 Jan 2022filed 6 Jan 2022 | AGEN AgenusBiotechnology | SEC FORM 4 Sold | $118K38,679 at $3.06 | filing |
| 4 Jan 2022filed 6 Jan 2022 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 4 Jan 2022filed 6 Jan 2022 | AGEN AgenusBiotechnology | SEC FORM 4 Code M | —100,000 | filing |
| 2 Jan 2022filed 4 Jan 2022 | AGEN Agenusoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
News
ImageneBio (NASDAQ:IMA) versus Agenus (NASDAQ:AGEN) Financial SurveyAGEN · dailypolitical.com · 11 Oct 2026Armenia Grants First Marketing Authorizations for Agenus' BOT+BAL in Previously Treated MSS Metastatic Colorectal CancerAGEN · elliotlakestandard.ca · 8 Oct 2026
0 headlines in the last 90 days name Steven J. O'Day; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.